News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
253 Results
Type
Article (10)
Press Release (243)
Section
Business (97)
Deals (13)
Drug Development (12)
FDA (7)
News (132)
Policy (15)
Tag
Alliances (5)
Approvals (7)
Clinical research (12)
Collaboration (1)
Data (1)
Earnings (62)
Events (51)
FDA (7)
GLP-1 (1)
Government (3)
Healthcare (1)
IPO (13)
NextGen: Class of 2025 (1)
People (35)
Phase II (3)
Phase III (9)
Pipeline (1)
Regulatory (14)
Supply chain (1)
United States (14)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (25)
2025 (4)
2024 (25)
2023 (30)
2022 (22)
2021 (28)
2020 (30)
2019 (7)
2018 (1)
2017 (1)
2016 (11)
2015 (13)
2014 (21)
2013 (13)
2012 (12)
2011 (19)
2010 (14)
Location
Africa (1)
Asia (4)
Australia (2)
Europe (5)
New Jersey (14)
South America (1)
253 Results for "cormedix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 26, 2025
·
11 min read
Press Releases
CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025
March 19, 2025
·
1 min read
Press Releases
CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
January 21, 2025
·
3 min read
Press Releases
CorMedix Inc. Added to Nasdaq Biotechnology Index
December 20, 2024
·
1 min read
Policy
CorMedix Inc. Receives FDA Feedback on Potential Label Expansion
CorMedix Inc. announced that the U.S. Food and Drug Administration has provided feedback to the Company’s request to discuss development plans for additional indications for DefenCath.
June 18, 2024
·
4 min read
Press Releases
CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update
January 7, 2025
·
5 min read
Pharm Country
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
CorMedix Inc. announced that the Center for Medicare & Medicaid Services has determined that DefenCath® qualifies for pass-through status under the hospital Out-Patient Prospective Payment System.
June 6, 2024
·
3 min read
Business
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider
CorMedix Inc. today announced that it has entered into a multi-year commercial supply contract with a top tier midsized dialysis provider for the supply of DefenCath ® (taurolidine and heparin).
May 28, 2024
·
3 min read
Press Releases
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
November 4, 2024
·
1 min read
Pharm Country
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
CorMedix Inc. announced that it has entered into a 5-year commercial supply contract with Florida-based dialysis provider, ARC Dialysis, LLC for the supply of DefenCath®.
April 8, 2024
·
3 min read
1 of 26
Next
